Medibios Labs.
Ticker > Company >

Medibios Labs. share price

Medibios Laboratories Ltd.

SECTOR: Pharmaceuticals & Drugs  1973   0   0

The company is currently not listed and is under IPO, so all the data might not be available.
*It is just an analytical rating of the company and not an investment advice.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year20.71%
3 Year17.1%
5 Year12.65%

Profit Growth

1 Year0.94%
3 Year31.85%
5 Year42.63%

ROE%

1 Year23.63%
3 Year26.42%
5 Year23.55%

ROCE %

1 Year26.44%
3 Year31.03%
5 Year27.55%

Debt/Equity

0.390514251745006

Price to Cash Flow

0

Interest Cover Ratio

10.3218606293229

CFO/PAT (5 Yr. Avg.)

1.04393259181243

 Strengths

  • The company has shown a good revenue growth of 17.1043773811823% for the Past 3 years.
  • Company has been maintaining healthy ROE of 26.4160093626985% over the past 3 years.
  • Company has been maintaining healthy ROCE of 31.0326941437975% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 10.3218606293229.
  • The company has an efficient Cash Conversion Cycle of 59.9496682826922 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.04393259181243.

 Limitations

 Looks like the company does not have any serious limitations.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
Net Sales 35.88 37.15 40.06 49.42 59.65
Total Expenditure 31.62 31.41 31.68 38 49.1
Operating Profit 4.25 5.73 8.38 11.42 10.56
Other Income 0.34 0.08 0.02 0.03 0.3
Interest 1.35 1.01 1.4 1.41 0.83
Depreciation 1.24 1.17 2.05 1.68 2.3
Exceptional Items 0 0 0 0 0
Profit Before Tax 2 3.63 4.96 8.37 7.73
Tax 0.66 1.2 1.76 2.85 2.16
Net Profit 1.34 2.43 3.21 5.52 5.57
Adjusted EPS (Rs.) 1.89 3.42 4.51 7.77 7.84

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
Equity and Liabilities
Share Capital 2.37 7.1 7.1 7.1 7.1
Total Reserves 6.97 4.59 7.66 13.29 19.66
Borrowings 0.02 1.49 4.61 3.22 4.24
Other N/C liabilities 5.53 5.46 4.68 4.32 3.64
Current liabilities 16 18.29 10.37 14.45 17.75
Total Liabilities 30.89 36.93 34.42 42.39 52.4
Assets
Net Block 15.9 17.26 18.3 19.84 20.66
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 1.24 1.24 1.24 1.27
Loans & Advances 0.46 0.17 0.17 0.18 0.17
Other N/C Assets 0.35 0.21 0.14 0.11 0.79
Current Assets 14.18 18.05 14.56 21.01 29.49
Total Assets 30.89 36.93 34.42 42.39 52.4
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018
Profit from operations 8.37 7.73
Adjustment 1.6 2.08
Changes in Assets & Liabilities -5.07 -6.76
Tax Paid 0 0
Operating Cash Flow 4.89 3.05
Investing Cash Flow -3.07 -3.64
Financing Cash Flow -1.74 0.39
Net Cash Flow 0.08 -0.2

Corporate Actions

Company News

 No Latest News available for this company.
Report us
Last Updated on:
Brief about Medibios Labs.
X